Iceland· IS-EU/1/14/979/009-012
Ofev
A nintedanib product containing nintedanibum inn, registered in Iceland by Boehringer Ingelheim International GmbH*. The same ATC class is registered in 14 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Nintedanib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EX09 (nintedanib), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Nintedanib · ATC L01EX09
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of nintedanib costs, country by country.
Normalised to the WHO defined daily dose (0.38 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Nintedanib · price per daily dose (0.38 g)
USD · FX 28 Sept 2026
- US United States$51.13 (acquisition cost)
- CH Switzerland$34.12
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Nintedanibum INN
- Manufacturer
- Boehringer Ingelheim International GmbH*
- Country
- Iceland (IS)
- ATC code
- L01EX09
- ATC class
- Nintedanib
- Defined daily dose
- 0.38 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean42648460 stk x1 stsk.þISK 61790
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
160 interactions on record for nintedanib.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nintedanib · interactions on record
160 records
- 21 severe
- 139 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- DexamethasoneH02AB02severe
- RifampicinJ04AB02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nintedanib in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainOFEV 25 MG CAPSULAS BLANDASBoehringer Ingelheim International Gmbh
- FranceOFEV 25 mg, capsule molleBOEHRINGER INGELHEIM INTERNATIONAL
- NorwayOfevBoehringer Ingelheim International GmbH
- PolandOfevBoehringer Ingelheim International GmbH
- SwedenOfev 25 mg Kapsel, mjukBoehringer Ingelheim International GmbH
- NetherlandsGevesla 100 mg, zachte capsulesSandoz B.V.
- GermanyNintedanibEugia Pharma (Malta) Limited
- United KingdomNintedanib 100mg capsulesDr Reddy's Laboratories (UK) Ltd
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Nintedanib Cipla, Nintedanib Ratiopharm
- Belgium · Nintedanib Accordpharma, Nintedanib Eg
- Cyprus · Nintedanib Teva
- Czechia · Nintedanib Glenmark, Nintedanib Sandoz
- Germany · Nintedanib, Nintedanib 1 A Pharma
- Denmark · Nintedanib "sandoz", Nintedanib Glenmark
- Estonia · Agarf, Nintedanib Sandoz
- Spain · Nintedanib, Nintedanib Accordpharma
- Finland · Nintedanib Glenmark, Nintedanib Ratiopharm
- France · Nintedanib Arrow, Nintedanib Biogaran
- United Kingdom (Northern Ireland) · Nintedanib, Nintedanib Accord Healthcare
- Greece · Nifib, Nindraf
- Croatia · Gevesla, Nintedanib Accordpharma
- Hungary · Nintedanib Accordpharma, Nintedanib Onkogen
- Ireland · Nintedanib Accordpharma, Nintedanib Clonmel
- Italy · Nintedanib Accordpharma, Nintedanib Aurobindo
- Liechtenstein · Nintedanib Accord, Nintedanib Viatris
- Lithuania · Agarf, Nintedanib Sandoz
- Luxembourg · Nintedanib Eg, Nintedanib Eurogenerics
- Latvia · Agarf, Nintedanib Sandoz
- Malta · Nifiden Adalvo, Nintedanib Adalvo
- Netherlands · Gevesla, Nintedanair
- Norway · Nintedanib Accord, Nintedanib Devatis
- Poland · Nintedanib, Nintedanib Accordpharma
- Portugal · Nintedanib Accordpharma, Nintedanib Eugia
- Romania · Gevesla, Nintedanib Dr. Reddy’s
- Sweden · Nintedanib Devatis, Nintedanib Glenmark
- Slovenia · Nintedanib Accordpharma, Nintedanib Stada
- Slovakia · Nintedanib Stada, Nintedanib Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7f032aec-2649-4a67-b04d-d906740d78e0 GET /v1/drugs/7f032aec-2649-4a67-b04d-d906740d78e0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Mjúkt hylki",
"source": "lyfjastofnun",
"atc_raw": "L01EX09",
"marketed": true,
"strength": "25 mg",
"ma_number": "EU/1/14/979/009-012",
"substance": "Nintedanibum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í lungnalækningum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "45700"
}See everything about nintedanib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.